Back to search

Article

A Promising Liposomal Vaccine Candidate Against Epstein–Barr Virus: An In Vitro Evaluation

2025-10-03

Abstract excerpt

Epstein-Barr virus (EBV) is a highly prevalent oncogenic herpesvirus associated with infectious mononucleosis, multiple malignancies and autoimmune disorders. Despite its global disease burden, no licensed vaccine is currently available. In this study, we developed PEGylated liposomes encapsulating full-length gp350 with MPLA adjuvant, systematically modulating DOPC- versus DOPE-based bilayers to reveal how lipid...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bf5e9ecc-efab-5922-b2a9-b8331296e37b
DOI
10.22541/au.175952216.64923020/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Promising Liposomal Vaccine Candidate Against Epstein–Barr Virus: An In Vitro EvaluationDOI 10.22541/au.175952216.64923020/v1
Select a neighboring publication to make it the new centre.